Results 161 to 170 of about 30,927 (236)

Correction: Ibrutinib as treatment for Bing-Neel syndrome reclassified as glioblastoma: a case report. [PDF]

J Med Case Rep
Gravesen CD, Chanchiri I, Kristensen IB, Jensen MB, Harbo FSG, Dahlrot RH.   +5 more
europepmc   +1 more source

Bruton's Tyrosine Kinase (BTK) Mutations in Chronic Lymphocytic Leukemia (CLL): A Clinical View. [PDF]

Mediterr J Hematol Infect Dis
Molica S, Allsup D.
europepmc   +1 more source

Statin use and survival in CLL/SLL treated with ibrutinib: pooled analysis of 4 randomized controlled trials. [PDF]

Blood Adv
Abuhelwa AY, Almansour SA, Brown JR, Al-Shamsi HO, Abuhelwa Z, Kharaba Z, Bustanji Y, Semreen MH, Ali S, Alhuraiji A, McKinnon RA, Sorich MJ, Alzoubi KH, Hopkins AM.   +13 more
europepmc   +1 more source

Ibrutinib outperforms FCR in CLL [PDF]

Nature Reviews Clinical Oncology, 2019
openaire   +2 more sources

Disseminated Nocardiosis in a Patient with Chronic Lymphocytic Leukemia Treated with Ibrutinib: A Case Report. [PDF]

Infect Dis Clin Microbiol
Yaqoobi H, Demiroğlu YZ, Altunay H, Habeşoğlu MA, Asgarova T, Durdağ E.   +5 more
europepmc   +1 more source

The splicing modulator sudemycin induces a specific antitumor response and cooperates with ibrutinib in chronic lymphocytic leukemia [PDF]

, 2015
Aymerich, Marta, Campo, Elías, Colomer, Dolors, Lagisetti, Chandraiah, López Guerra, Mónica, López Otín, Carlos, Montraveta, Arnau, Rodríguez, Vanina, Roldán, Jocabed, Rosich, Laia, Villamor Casas, Neus, Webb, Thomas R., Xargay-Torrent, Sçilvia   +12 more
core   +1 more source

Ibrutinib in Elderly Patients with Chronic Lymphocytic Leukemia: Adverse Event Incidence, Management, and Outcomes in a Canadian Real-World Setting. [PDF]

Curr Oncol
Othman I, Moossavi SZM, Bayati S, Chang YS, Sanjoy S, Grzyb K, Sy E, Cropper K, Kassir S, Sabry W.   +9 more
europepmc   +1 more source

Ibrutinib alone or with dexamethasone for relapsed or relapsed and refractory multiple myeloma: Phase 2 trial results [PDF]

, 2018
et al,, Stockerl-Goldstein, Keith E, Vij, Ravi   +2 more
core   +1 more source

“Hemophagocytic Lymphohistiocytosis after EBV reactivation and ibrutinib treatment in relapsed/refractory Chronic Lymphocytic Leukemia”

, 2017
Maurizio Cavallari, Maria Ciccone, Simonetta Falzoni, Francesco Cavazzini, Luca Formigaro, Francesco Di Virgilio, Antonella Rotola, Gian Matteo Rigolin, Antonio Cuneo   +8 more
openalex   +1 more source

Richter transformation in diffuse large B-cell lymphoma in patients with chronic lymphocytic leukemia receiving ibrutinib: risk factors and outcomes. [PDF]

Leukemia
Pepe S, Vitale C, Giannarelli D, Visentin A, Sanna A, Frustaci AM, Olivieri J, Quaglia FM, Gozzetti A, Sportoletti P, Murru R, Innocenti I, Reda G, Pupo L, Levato L, Porrazzo M, Ilariucci F, Moia R, Foglietta M, Rigolin GM, Chiurazzi F, Trastulli F, Cellini A, Deodato M, Martino E, Laurenti L, Coscia M, Cuneo A, Gaidano G, Rossi D, Gentile M, Mauro FR.   +31 more
europepmc   +1 more source